Catalyst Pharma (CPRX)
NASDAQ:CPRX
Holding CPRX?
Track your performance easily

Catalyst Pharma (CPRX) Technical Analysis

2,061 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Catalyst Pharma’s (CPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.43, suggesting Catalyst Pharma is a Buy.
Catalyst Pharma’s (CPRX) 20-Day exponential moving average is 19.88, while Catalyst Pharma’s (CPRX) share price is $21.18, making it a Buy.
Catalyst Pharma’s (CPRX) 50-Day exponential moving average is 18.82, while Catalyst Pharma’s (CPRX) share price is $21.18, making it a Buy.

Catalyst Pharma (CPRX) Pivot Points

Sep 20, 2024, 12:16 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.79
20.06
20.25
20.52
20.71
20.98
21.17
Fibonacci
20.06
20.24
20.34
20.52
20.70
20.80
20.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CPRX) Moving Averages

Sep 20, 2024, 12:16 AM
Period
Simple
Exponential
MA5
20.36Buy
20.29Buy
MA10
19.97Buy
20.14Buy
MA20
20.13Buy
19.88Buy
MA50
18.62Buy
18.82Buy
MA100
17.13Buy
17.66Buy
MA200
16.12Buy
16.31Buy
Catalyst Pharma’s (CPRX) 10-Day exponential moving average is 20.14, while Catalyst Pharma’s (CPRX) share price is $21.18, making it a Buy.
Catalyst Pharma’s (CPRX) 100-Day exponential moving average is 17.66, while Catalyst Pharma’s (CPRX) share price is $21.18, making it a Buy.
Catalyst Pharma’s (CPRX) stock price is $21.18 and Catalyst Pharma’s (CPRX) 50-day simple moving average is 18.62, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $21.18 and Catalyst Pharma’s (CPRX) 100-day simple moving average is 17.13, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $21.18 and Catalyst Pharma’s (CPRX) 200-day simple moving average is 16.12, creating a Buy signal.

Catalyst Pharma (CPRX) Technical Indicators

Sep 20, 2024, 12:16 AM
Name
Value
Implied Action
RSI (14)
62.11
Neutral
STOCH (9,6)
80.26
Sell
STOCHRSI (14)
80.26
Sell
MACD (12,26)
0.43
Buy
ADX (14)
25.91
Neutral
Williams %R
-20.11
Buy
CCI (14)
70.27
Neutral
ATR (14)
0.65
-
Ultimate Oscillator
52.25
Neutral
ROC
0.25
Buy
Catalyst Pharma’s (CPRX) Relative Strength Index (RSI) is 62.11, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Trend Strength Indicator (ADX) is 25.91, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Commodity Channel Index (CCI) is 70.27, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Price Rate of Change (ROC) is 0.25, creating a Buy signal.

FAQ

Is CPRX a Buy, Hold, or Sell?
Based on CPRX’s technical indicators, CPRX is a Strong Buy.
    What is CPRX’s RSI (14)?
    CPRX’s RSI (14) is 62.11, which suggests CPRX is a Neutral.
      What is CPRX’s MACD?
      CPRX’s MACD is 0.43, which suggests CPRX is a Buy.
        What is CPRX’s 5-day moving average?
        CPRX’s 5-day moving average is 20.36, which suggests CPRX is a Buy.
          What is CPRX’s 20-day moving average?
          CPRX 20-day moving average is 20.13, which suggests CPRX is a Buy.
            What is CPRX’s 50-day moving average?
            CPRX’s 50-day moving average is 18.62, which suggests CPRX is a Buy.
              What is CPRX’s 200-day moving average?
              CPRX’s 200-day moving average is 16.12, which suggests CPRX is a Buy.
                What is CPRX’s Williams % R (14)?
                CPRX’s Williams % R (14) is -20.11, which suggests CPRX is a Buy.
                  What is CPRX’s CCI (14)?
                  CPRX’s CCI (14) is 70.27, which suggests CPRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis